Spyre Therapeutics Inc (SYRE)

Other Income/Expenses (Net)

$5.44M

Quarterly · Period ending: · USD

SYRE logo

SYRE Other Income/Expenses (Net)

Latest reported$5.44M
SYRE Quarterly Other Income/Expenses (Net) (-$663.00K → $5.44M)
High-resolution chart · PNG

SYRE other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
5,439,000
-23,364,000
-5,358,000
45,705,000
5,218,000
8,779,000
4,958,000
-13,618,000
5,310,000
3,949,000
-17,266,000
-21,767,000
-57,828,000
348,000
378,000
312,000
109,000
5,000
19,000
12,000
-33,000
-9,000
62,000
90,000
142,000
294,000
414,000
573,000
603,000
490,000
407,000
326,000
256,000
126,000
143,000
124,000
88,000
84,000
60,000
63,000
65,000
20,000
10,000
4,000
5,000
1,000
0
-110,000
-670,000
-663,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.